Clinical Trial Update: Diagnosis/Pathophysiology of Glucocorticoid Remediable Aldosteronism Hypertension

View source ↗

Summary

An NIH NHLBI clinical trial update describes diagnosis and pathophysiology of glucocorticoid-remediable aldosteronism as a cause of hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Glucocorticoid-remediable Aldosteronism
• Hypertension

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Hypertension | Status: COMPLETED